Mechanism ColonBroom's GLP-1 positioning is backed by real fiber science: fermentable fiber increases short-chain fatty acids, which activate receptors on gut L-cells that release GLP-1 and PYY, both of which increase fullness
The decision to use compounded medications is guided by the licensed provider's medical judgment
Originally developed for the treatment of type 2 diabetes, these medications have demonstrated remarkable efficacy in weight loss, sparking a global surge in demand and transforming the market
This is not a free license to overeat
TRC Healthcare Editor Hosts: Stephen Small, PharmD, BCPS, BCPPS, BCCCP, CNSC Don Weinberger, PharmD, PMSP Guest: Sara Klockars, PharmD, BCPS (TRC Healthcare Editor, Dermatology Specialist) CE Information: None of the speakers have anything to disclose